SCHEMBL14693420

SCHEMBL14693420

Nc1cncc2c1c(I)nn2-c1cccc([N+](=O)[O-])c1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 6/20 0.46
▸ RAB9A P51151 4/20 0.46
▸ NPC1 O15118 3/20 0.46
▸ HPGD P15428 3/20 0.46
▸ GFER P55789 2/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP3A4 P08684 1/20 0.46
▸ CYP2C9 P11712 1/20 0.46
▸ CYP2C19 P33261 1/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.45
▸ MEN1 O00255 2/20 0.44
▸ KMT2A Q03164 2/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ GAA P10253 1/20 0.44
▸ CASP3 P42574 1/20 0.44
▸ HTT P42858 1/20 0.44
▸ SENP7 Q9BQF6 1/20 0.44
▸ MAPK14 Q16539 1/20 0.43
▸ FGFR1 P11362 1/20 0.42
▸ ABHD16A O95870 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6667087 0.85 MAPT (0.41) MAPTRAB9ANPC1SMN1; SMN2MEN1
SCHEMBL14693601 0.77 RAB9A (0.45) MAPTRAB9ANPC1HPGDGFER
SCHEMBL29218170 0.75 FGFR1 (0.53) MAPTRAB9ANPC1HPGDGFER
SCHEMBL30999883 0.72 FGFR1 (0.50) MAPTRAB9ANPC1HPGDGFER
SCHEMBL30163022 0.68 NPC1 (0.42) MAPTRAB9ANPC1CYP2C9MEN1
SCHEMBL14693559 0.68 MAPK14 (0.44) RAB9ANPC1SMN1; SMN2MEN1KMT2A
SCHEMBL11333428 0.67 RAB9A (0.62) MAPTRAB9ANPC1HPGDGFER
SCHEMBL29366393 0.67 ALDH1A1 (0.51) MAPTHPGDGFERMEN1KMT2A
SCHEMBL543835 0.66 MAPT (0.56) MAPTRAB9ANPC1HPGDGFER
SCHEMBL24933448 0.65 SMN1; SMN2 (0.59) RAB9ANPC1HPGDSMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8377946-B1 Pyrazolo[3,4-d]pyrimidine and pyrrolo[2,3-d]pyrimidine compounds as kinase inhibitors PHARMACYCLICS, INC. (US) 2013-02-19 — — US disclosed
Send feedback